Skip to content

interventional program to promote the maternal role adaptation, and self-efficacy

Examination of the Impact of an Interventional Program to promote the maternal role adaptation and self-efficacy of Adolescent Mothers in postpartum care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240920063102N1
Enrollment
50
Registered
2025-01-23
Start date
2024-10-22
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy and postpartum.

Interventions

Intervention 1: Intervention group: In the intervention group from the 32nd to the 34th week of pregnancy, in addition to routine pregnancy care based on the national protocol, 6 to 8 teenage mothers

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 20 Years

Inclusion criteria

Inclusion criteria: Age 15-20 years First pregnancy Gestational age 32 to 34 weeks Absence of abnormalities in the fetus Iranian nationality Resident of Isfahan city Low-risk singleton pregnancy Absence of depression, chronic disease, and drug use in the mother.

Exclusion criteria

Exclusion criteria: Unwillingness to continue participating in the study, Stillbirth, Premature delivery (under 37 weeks of pregnancy), Presence of abnormalities in the baby, Long-term hospitalization of the baby in the NICU Occurrence of serious complications after delivery and long-term hospitalization of mothers such as severe pre-eclampsia, severe infection

Design outcomes

Primary

MeasureTime frame
Self-efficacy, and maternal role adaptation. Timepoint: Before intervention, immediatly after intervention, 10days after childbirth, and 42 days after childbirth. Method of measurement: Postpartum self-efficacy scale , and maternal role adaptation questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsamaneh Youseflu

Esfahan University of Medical Sciences

s.yoseflu@yahoo.com+98 912 882 6741

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026